durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['lcsm,(-blcsm)', 'lung']
perioperative immunotherapy + chemo promising in early-stage non-small cell lung cancer. perioperative immuno well-tolerated. but control arm is still chemo. will this be new standard of care? dr john heymach #aacr23 #lcsm (7/11) 
LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.